Insider Transactions in Q1 2023 at Mimedx Group, Inc. (MDXG)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
Robert Benjamin Stein President, Regenerative Med. |
BUY
Grant, award, or other acquisition
|
Direct |
135,065
+25.18%
|
$540,260
$4.62 P/Share
|
|
Mar 13
2023
|
Peter M Carlson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,455
+17.23%
|
$561,820
$4.62 P/Share
|
|
Mar 13
2023
|
William Frank Iv Hulse General Counsel and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
136,364
+22.33%
|
$545,456
$4.62 P/Share
|
|
Mar 13
2023
|
William Lawrence Phelan Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,030
+21.44%
|
$212,120
$4.62 P/Share
|
|
Mar 07
2023
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
11,308
-3.24%
|
$45,232
$4.24 P/Share
|
|
Mar 07
2023
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,056
-2.21%
|
$48,224
$4.24 P/Share
|
|
Mar 07
2023
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,396
-2.35%
|
$13,584
$4.24 P/Share
|
|
Mar 07
2023
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
12,355
-4.43%
|
$49,420
$4.24 P/Share
|
|
Feb 23
2023
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Open market or private sale
|
Direct |
15,555
-4.26%
|
$62,220
$4.53 P/Share
|
|
Feb 23
2023
|
Peter M Carlson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,000
-3.36%
|
$76,000
$4.5 P/Share
|
|
Feb 13
2023
|
Ricci S Whitlow Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
462,857
+50.0%
|
$1,388,571
$3.5 P/Share
|